Cardiovascular Diseases Clinical Trial
— Dx-AFOfficial title:
Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients With the Use of a VDD-ICD Lead: The Dx-AF Study
Verified date | April 2021 |
Source | Unity Health Toronto |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study aims to compare the Dx-ICD system (experimental) to standard VVI-ICD (control) on the ability to diagnose silent AF in patients without prior AF receiving an ICD for standard indications.
Status | Active, not recruiting |
Enrollment | 188 |
Est. completion date | March 31, 2022 |
Est. primary completion date | March 31, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 51 Years and older |
Eligibility | Inclusion Criteria: - Patients with ischemic or non-ischemic cardiomyopathy, - LVEF<50%, scheduled for primary or secondary prevention ICD - Treating physicians feel that the use of single chamber ICD is appropriate - No ECG-documented history of AF or flutter - Age > 50 years Exclusion Criteria: - Known AF or flutter - Current use of class I or III anti-arrhythmic medications - Participants unwilling to attend study follow-up visits, considered unreliable for compliance or with an anticipated life expectancy less than 3 years |
Country | Name | City | State |
---|---|---|---|
Canada | Royal Alexandra Hospital | Edmonton | Alberta |
Canada | IUCPQ - Institut universitaire de cardiologie et de pneumologie de Québec | Laval | Quebec |
Canada | HSCM - L'Hôpital du Sacré-Coeur de Montréal | Montreal | Quebec |
Canada | Saint John Regional Hospital | Saint John | New Brunswick |
Canada | CHUS - Centre Hospitalier Universitaire de Sherbrooke | Sherbrooke | Quebec |
Canada | Health Sciences North | Sudbury | Ontario |
Canada | Scarborough and Rouge Hospital - Centenary Site | Toronto | Ontario |
Canada | Sunnybrook Health Sciences Centre | Toronto | Ontario |
Canada | Vancouver Island Health Authority | Vancouver | British Columbia |
Lead Sponsor | Collaborator |
---|---|
Unity Health Toronto | Applied Health Research Centre, Biotronik Canada Inc |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Atrial Fibrillation or atrial flutter lasting at least 6 minutes | Atrial Fibrillation or atrial flutter lasting at least 6 minutes detected by the ICD, ECG, Holter monitor or telemetry. | During the entire time of follow up - 3 years | |
Secondary | Need for any ICD lead repositioning or replacement | Composite outcome of serious device-related complications occurring in the 60 days from the time of ICD insertion. | 60 days | |
Secondary | Pneumothorax | Composite outcome of serious device-related complications occurring in the 60 days from the time of ICD insertion. | 60 days | |
Secondary | New pericardial effusion | Composite outcome of serious device-related complications occurring in the 60 days from the time of ICD insertion. | 60 days | |
Secondary | Cardiac tamponade | Composite outcome of serious device-related complications occurring in the 60 days from the time of ICD insertion. | 60 days | |
Secondary | Procedure-related death or wound infection | Composite outcome of serious device-related complications occurring in the 60 days from the time of ICD insertion. | 60 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|